# Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers

> **NCT02778789** · — · COMPLETED · sponsor: **University of Erlangen-Nürnberg Medical School** · enrollment: 66 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tocilizumab
- **DRUG:** TNF-alpha Inhibitor

## Key facts

- **NCT ID:** NCT02778789
- **Lead sponsor:** University of Erlangen-Nürnberg Medical School
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10
- **Primary completion:** 2017-09-30
- **Final completion:** 2018-03-31
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2019-09-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02778789

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02778789, "Comparing the Efficacy of Periarticular Bone Structure in Patients Treated With Either Tocilizumab or Tumor Necrosis Factor Blockers". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02778789. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*